These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19086374)

  • 21. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
    Meinkoth JH; Meyers KM
    Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease.
    Favaloro EJ; Koutts J
    Pathology; 1997 Nov; 29(4):385-91. PubMed ID: 9423220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease.
    Callan MB; Giger U; Catalfamo JL
    Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.
    Favaloro EJ; Oliver S; Mohammed S; Vong R
    Haemophilia; 2020 May; 26(3):503-512. PubMed ID: 32159272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.
    Ni Y; Nesrallah J; Agnew M; Geske FJ; Favaloro EJ
    Int J Lab Hematol; 2013 Apr; 35(2):170-6. PubMed ID: 23107512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a questionnaire to predict von Willebrand disease status and characterize hemorrhagic signs in a population of dogs and evaluation of a diagnostic profile to predict risk of bleeding.
    Burgess HJ; Woods JP; Abrams-Ogg AC; Wood RD
    Can J Vet Res; 2009 Oct; 73(4):241-51. PubMed ID: 20046625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source.
    Favaloro EJ
    Thromb Haemost; 2000 Jan; 83(1):127-35. PubMed ID: 10669166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
    Favaloro EJ; Mohammed S
    Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.
    Riddell AF; Jenkins PV; Nitu-Whalley IC; McCraw AH; Lee CA; Brown SA
    Br J Haematol; 2002 Jan; 116(1):187-92. PubMed ID: 11841416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms.
    Favaloro EJ; Facey D; Grispo L
    Am J Clin Pathol; 1995 Sep; 104(3):264-71. PubMed ID: 7677113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
    Favaloro EJ
    Semin Thromb Hemost; 2007 Nov; 33(8):727-44. PubMed ID: 18175279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory Testing for von Willebrand Factor Antigen (VWF:Ag).
    Favaloro EJ; Mohammed S; Patzke J
    Methods Mol Biol; 2017; 1646():403-416. PubMed ID: 28804844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
    Lattuada A; Preda L; Sacchi E; Gallo L; Federici AB; Rossi E
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):505-11. PubMed ID: 15311161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.
    Johnstone IB
    Can Vet J; 1999 Sep; 40(9):645-8. PubMed ID: 10495907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.